Synthesis of aurones and their inhibitory effects on nitric oxide and PGE 2 productions in LPS-induced RAW 264.7 cells

Bioorganic and Medicinal Chemistry Letters

Volumn 21, Issue 15, 2011, Pages 4520-4523

  Shin, Seo Young ^a   Shin, Min Cheol ^a   Shin, Ji Sun ^a   Lee, Kyung Tae ^a   Lee, Yong Sup ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Anti inflammatory; Aurone; Nitric oxide; Prostaglandin E 2; Sulfuretin

Indexed keywords

2 (2 HYDROXYBENZYLIDENE) 6 METHOXYBENZOFURAN 3(2H)ONE; 2 (2,4 DIHYDROXYBENZYLIDENE) 6 HYDROXYBENZOFURAN 3(2H)ONE; 2 (2,4 DIHYDROXYBENZYLIDENE) 6 METHOXYBENZOFURAN 3(2H)ONE; 2 (3 HYDROXYBENZYLIDENE) 6 METHOXYBENZOFURAN 3(2H)ONE; 2 (3,4 DIHYDROXYBENZYLIDENE) 6 METHOXYBENZOFURAN 3(2H)ONE; 2 (3,4 DIMETHOXYBENZYLIDENE) 6 HYDROXYBENZOFURAN 3(2H)ONE; 2 (3,5 DIMETHOXYBENZYLIDENE) 6 HYDROXYBENZOFURAN 3(2H)ONE; 2 (4 HYDROXYBENZYLIDENE) 6 METHOXYBENZOFURAN 3(2H)ONE; 6 HYDROXY 2 (2 HYDROXYBENZYLIDENE)BENZOFURAN 3(2H)ONE; 6 HYDROXY 2 (2 METHOXYBENZYLIDENE)BENZOFURAN 3(2H)ONE; 6 HYDROXY 2 (3 HYDROXYBENZYLIDENE)BENZOFURAN 3(2H)ONE; 6 HYDROXY 2 (3 METHOXYBENZYLIDENE)BENZOFURAN 3(2H)ONE; 6 HYDROXY 2 (3,4,5 TRIHYDROXYBENZYLIDENE)BENZOFURAN 3(2H)ONE; 6 HYDROXY 2 (4 HYDROXYBENZYLIDENE)BENZOFURAN 3(2H)ONE; 6 HYDROXY 2 (4 METHOXYBENZYLIDENE)BENZOFURAN 3(2H)ONE; 6 METHOXY 2 (2 METHOXYBENZYLIDENE)BENZOFURAN 3(2H)ONE; 6 METHOXY 2 (3 METHOXYBENZYLIDENE)BENZOFURAN 3(2H)ONE; ANTIINFLAMMATORY AGENT; AURONE DERIVATIVE; HYDROXYL GROUP; NITRIC OXIDE; PROSTAGLANDIN E2; SULFURETIN; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; MACROPHAGE; NONHUMAN; PROSTAGLANDIN SYNTHESIS INHIBITION; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTI-INFECTIVE AGENTS; BENZOFURANS; CELL LINE, TUMOR; DINOPROSTONE; LIPOPOLYSACCHARIDES; MICE; NITRIC OXIDE;

TOXICODENDRON VERNICIFLUUM;

EID: 79960342853     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2011.05.117     Document Type: Article

References (19)

1. T.M. Oberyszyn Front. Biosci. 12 2007 2993
2. H.Y. Yun, V.L. Dawson, and T.M. Dawson Crit. Rev. Neurobiol. 10 1996 291
3. B. Hinz, and K.J. Brune Pharmacol. Exp. Ther. 300 2002 367
4. J.W. Choi, B.J. Yoon, Y.N. Han, S.K. Lee, K.-T. Lee, and H.-J. Park Nat. Prod. Sci. 9 2003 97
5. I.T. Kim, Y.M. Park, K.M. Shin, J.H. Ha, J.W. Choi, H.J. Jung, H.-J. Park, and K.-T. Lee J. Ethnopharmacol. 94 2004 165
6. M.J. Jung, H.Y. Chung, S.S. Kang, J.H. Choi, K.S. Bae, and J.S. Choi Arch. Pharm. Res. 6 2003 458
7. K.Y. Park, G.O. Jung, K.-T. Lee, J.W. Choi, M.Y. Choi, G.T. Kim, H.J. Jung, and H.-J. Park J. Ethnopharmacol. 90 2004 73
8. E.H. Lee, D.G. Song, J.Y. Lee, C.H. Pan, B.H. Um, and S.H. Jung Biol. Pharm. Bull. 31 2008 1626
9. M.-Y. Song, G.-S. Jeong, K.-B. Kwon, S.-O. Ka, H.-Y. Jang, J.-W. Park, Y.-C. Kim, and B.-H. Park Exp. Mol. Med. 42 2010 628
10. A.-L. Liu, H.-D. Wang, S.M. Lee, Y.-T. Wang, and G.-H. Du Bioorg. Med. Chem. 16 2008 7141
11. A. Detsi, M. Majdalani, C.A. Kontogiorgis, D. Hadjipavlou-Litina, and P. Kefalas Bioorg. Med. Chem. 17 2009 8073
12. R. Valclavikova, E. Kondrova, M. Ehrlichova, A. Boumendjel, J. Kovar, P. Stopka, P. Soucek, and I. Gut Bioorg. Med. Chem. 16 2008 2034
13. S. Okombi, D. Rival, S. Bonnet, A.-M. Mariotte, E. Perrier, and A. Boumendjel J. Med. Chem. 49 2006 329
14. J.-S. Shin, Y.M. Park, J.-H. Choi, H.-J. Park, M.C. Shin, Y.S. Lee, and K.-T. Lee Int. Immunopharmacol. 10 2010 943
15. A. Boumendjel, C. Beney, N. Deka, A.-M. Mariotte, M.A. Lawson, D. Trompier, H. Baubichon-Cortay, and A.D. Pietro Chem. Pharm. Bull. 50 2002 854
16. C.-Y. Lee, E.-H. Chew, and M.-L. Go Eur. J. Med. Chem. 45 2010 2957
17. E. Wong Phytochemistry 6 1967 1227
18. K.Z. Laczkowski, M.M. Pakulski, M.P. Krzeminski, P. Jaisankar, and M. Zaidlewicz Tetrahedron: Asymmetry 19 2008 788
19. J.Y. Kim, S.J. Park, K.J. Yun, Y.W. Cho, H.J. Park, and K.-T. Lee Eur. J. Pharmacol. 584 2008 175